Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2025-12-24 @ 4:02 PM
NCT ID: NCT02272166
Eligibility Criteria: Inclusion Criteria: * 18-45 years old women * American Society of Anesthesiologists (ASA) score 1-2 * Affiliated to a social security system * Undergoing an ambulatory surgery during more than 15 minutes with general anesthesia and control of upper airways (tracheal intubation or supraglottic mask or facial mask ventilation) for oocytes punction before in vitro fertilization * General anesthesia occuring between 8 and 10 am with respect of pre-operative fasting rules * APFEL risk score for nausea and vomiting ≤ 2/4 * Ability to understand and read french * Signature of understood consent Exclusion Criteria: * Other surgery than oocytes punction * Cognitive dysfunction * Undernutrition or risk factor of undernutrition (evolutive neoplasia, chronic alcoholism …) * BMI ≥ 35 kg/m² * Eating disorders * Diabetes mellitus * Chronic treatment with drugs modifying feeding behavior : * Benzodiazepines * Inhibitors of serotonin reuptake * Others * Non respect of pre-operative fasting rules * Indication for rapid sequence induction (gastro-oesophageal reflux, absence of gastric emptying …) * Contraindication to propofol (allergia to propofol, soybean or peanuts, past history of propofol infusion syndrome, unstable cardiovascular disease) or to sevoflurane (past history of malignant hyperthermia, epilepsy or liver disorders after administration of a halogenated anesthetic) * Pregnant or breastfeeding woman * Involvement in another clinical trial under 4 previous weeks
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 45 Years
Study: NCT02272166
Study Brief:
Protocol Section: NCT02272166